Ramil A. Bashirov
Research Subjects
Ramil A. Bashirov has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Edgar Kh. Samsonyan
Russian University of Medicine
5 shared publications - Ekaterina V. Frolova
Hospital of the Centrosouz
5 shared publications - Sergei I. Emelyanov
Russian University of Medicine
5 shared publications - Dmitriy Yu. Bogdanov
Yevdokimov Moscow State University of Medicine and Dentistry
3 shared publications - M.A. Sekundova
Hospital of the Centrosouz of the Russian Federation
2 shared publications - I. A. Kurganov
Russian University of Medicine
1 shared publication
Latest Publications
- 27 October 2025
- Published by Media Sphere Publishing Group in Endoscopic Surgery
- Vol. 31 (5) , 56-61
Unresolved aspects of the search and removal of flat epithelial lesions of the colon
A significant part of epithelial neoplasia of the colon are the so-called flat neoplasms (lesions 0-IIa and 0-IIb according to the Paris endoscopic classification of superficial neoplastic lesions), which are sometimes called invisible due to the difficulty of detecting such lesions during screening colonoscopies. It has been proven that the removal of epithelial lesions of the colon during colonoscopy can significantly reduce mortality from colorectal cancer. In recent years, simpler and safer methods of endoscopic polypectomy have been used in everyday clinical practice to remove flat neoplasms. Of these methods, the most widely used worldwide is cold loop polypectomy, in which epithelial formations are cut off mechanically with a polypectomy loop without applying current. Cold loop polypectomy can also be performed on an outpatient basis, thereby preventing colorectal cancer directly during the initial examination. This method is safe and does not lead to undesirable complications. However, despite the simplicity of the method, there are several unresolved aspects of finding and removing flat epithelial formations of the colon: a detailed description of the localization of flat neoplasms for subsequent removal and control colonoscopies, incomplete cutting and getting stuck of the cold polypectomy loop in the polyp tissue when removing flat epithelial neoplasms larger than 8 mm, extraction of removed epithelial formations for histological examination, which are discussed and resolved in this article.
- 27 October 2025
- Published by Media Sphere Publishing Group in Endoscopic Surgery
- Vol. 31 (5) , 56-61
Unresolved aspects of the search and removal of flat epithelial lesions of the colon
A significant part of epithelial neoplasia of the colon are the so-called flat neoplasms (lesions 0-IIa and 0-IIb according to the Paris endoscopic classification of superficial neoplastic lesions), which are sometimes called invisible due to the difficulty of detecting such lesions during screening colonoscopies. It has been proven that the removal of epithelial lesions of the colon during colonoscopy can significantly reduce mortality from colorectal cancer. In recent years, simpler and safer methods of endoscopic polypectomy have been used in everyday clinical practice to remove flat neoplasms. Of these methods, the most widely used worldwide is cold loop polypectomy, in which epithelial formations are cut off mechanically with a polypectomy loop without applying current. Cold loop polypectomy can also be performed on an outpatient basis, thereby preventing colorectal cancer directly during the initial examination. This method is safe and does not lead to undesirable complications. However, despite the simplicity of the method, there are several unresolved aspects of finding and removing flat epithelial formations of the colon: a detailed description of the localization of flat neoplasms for subsequent removal and control colonoscopies, incomplete cutting and getting stuck of the cold polypectomy loop in the polyp tissue when removing flat epithelial neoplasms larger than 8 mm, extraction of removed epithelial formations for histological examination, which are discussed and resolved in this article.
- 13 February 2025
- Published by Media Sphere Publishing Group in Endoscopic Surgery
- Vol. 31 (1)
Percutaneous puncture endoscopic gastrostomy under ultrasound control with negative diaphanoscopy
Objective. Optimization the surgical technique of percutaneous puncture endoscopic gastrostomy (PEG) in patients with a typical and subcostal stomach with negative diaphanoscopy. Material and methods. In the period from 2021 to 2023, we studied the results of performing PEG under ultrasound control using an endoscopic balloon in 29 patients: 23 (79.3%) patients with a typical stomach location and 6 (20.7%) patients with a subcostal location, in whom it was not possible to use diaphanoscopy and manual palpation to determine the location of the primary puncture the anterior abdominal wall and the wall of the stomach for the subsequent installation of a gastrostomy tube for the purpose of long-term enteral nutrition. Results. Technical and clinical success in our study was achieved in 100% of cases. There were no intraoperative complications. All patients were provided with enteral nutrition access through a gastrostomy tube. The surgical intervention time ranged from 20 to 40 minutes. The minimum period of hospitalization was 4 days, the maximum period was 7 days. In the early postoperative period, 2 (6.9%) patients had local inflammation of the postoperative wound in the area of the gastrostomy tube placement. These patients underwent local antibiotic therapy with a positive effect. Conclusion. PEG under ultrasound control using an endoscopic balloon in patients who cannot use diaphanoscopy to determine the location of the primary puncture is an effective, convenient and safe method of gastrostomy formation. This technique allows you to complete the PEG procedure without resorting to other methods of gastrostomy formation. Also, our proposed method provides the possibility of removing the stomach below the costal arch for the successful installation of PEG in patients with subcostal stomach.
- 13 February 2025
- Published by Media Sphere Publishing Group in Endoscopic Surgery
- Vol. 31 (1)
Percutaneous puncture endoscopic gastrostomy under ultrasound control with negative diaphanoscopy
Objective. Optimization the surgical technique of percutaneous puncture endoscopic gastrostomy (PEG) in patients with a typical and subcostal stomach with negative diaphanoscopy. Material and methods. In the period from 2021 to 2023, we studied the results of performing PEG under ultrasound control using an endoscopic balloon in 29 patients: 23 (79.3%) patients with a typical stomach location and 6 (20.7%) patients with a subcostal location, in whom it was not possible to use diaphanoscopy and manual palpation to determine the location of the primary puncture the anterior abdominal wall and the wall of the stomach for the subsequent installation of a gastrostomy tube for the purpose of long-term enteral nutrition. Results. Technical and clinical success in our study was achieved in 100% of cases. There were no intraoperative complications. All patients were provided with enteral nutrition access through a gastrostomy tube. The surgical intervention time ranged from 20 to 40 minutes. The minimum period of hospitalization was 4 days, the maximum period was 7 days. In the early postoperative period, 2 (6.9%) patients had local inflammation of the postoperative wound in the area of the gastrostomy tube placement. These patients underwent local antibiotic therapy with a positive effect. Conclusion. PEG under ultrasound control using an endoscopic balloon in patients who cannot use diaphanoscopy to determine the location of the primary puncture is an effective, convenient and safe method of gastrostomy formation. This technique allows you to complete the PEG procedure without resorting to other methods of gastrostomy formation. Also, our proposed method provides the possibility of removing the stomach below the costal arch for the successful installation of PEG in patients with subcostal stomach.
- 7 June 2024
- Published by Media Sphere Publishing Group in Endoscopic Surgery
- Vol. 30 (3)
Results of using endoscopic stenting of the gastric outlet and duodenum with metal self-expanding stents
Objective. Evaluation of immediate and long-term results of endoscopic stenting (ES) of the stomach and duodenum in patients with stenotic unresectable tumors. Material and methods. In the period from 2016 to 2022, the results of ES of the stomach and duodenum with self-expanding metal stents were studied in 97 patients with stenotic unresectable tumors of the stomach and duodenum with the aim of providing palliative care. Results. No intraoperative complications were noted. In the early postoperative period, no cases of stent migration, perforation, or bleeding episodes were recorded. The rate of technical and clinical success of the operation in the study group was 96.9% of cases (94 patients); in 3 (3.1%) patients, clinical success was not achieved due to incomplete deployment of the stent in 1 patient or absolute non-expansion of the metal stent in 2 patients. In 21 (21.7%) patients in the study group, moderate symptoms of epigastric pain persisted after surgery, while chronic pain syndrome occurred in 4 (4.1%) patients in the postoperative period. 3 months after surgery, 5 (5.1%) patients experienced recurrent obstruction of the stent by a tumor through the stent cells; 9 (9.3%) patients experienced continued tumor growth with stenosis of the lumen. Repeated stent-in-stent ES for tumor stenosis of the stomach and duodenum was performed in 14 (14.4%) patients. Stent migration 3 months after ES of the stomach and duodenum was not recorded in any case. Three-month mortality overall was 14.4% due to progression of the underlying disease. Conclusion. ES of stenosing formations of the outlet of the stomach and duodenum demonstrates an effective and safe low-traumatic surgical intervention, which, as part of palliative care, can achieve a rapid reduction in the clinical symptoms of gastrostasis, rapid restoration of enteral nutrition, and ensure a low incidence of complications, thereby increasing the quality of life in patients with unresectable tumors of the stomach and duodenum.
- 7 June 2024
- Published by Media Sphere Publishing Group in Endoscopic Surgery
- Vol. 30 (3)
Results of using endoscopic stenting of the gastric outlet and duodenum with metal self-expanding stents
Objective. Evaluation of immediate and long-term results of endoscopic stenting (ES) of the stomach and duodenum in patients with stenotic unresectable tumors. Material and methods. In the period from 2016 to 2022, the results of ES of the stomach and duodenum with self-expanding metal stents were studied in 97 patients with stenotic unresectable tumors of the stomach and duodenum with the aim of providing palliative care. Results. No intraoperative complications were noted. In the early postoperative period, no cases of stent migration, perforation, or bleeding episodes were recorded. The rate of technical and clinical success of the operation in the study group was 96.9% of cases (94 patients); in 3 (3.1%) patients, clinical success was not achieved due to incomplete deployment of the stent in 1 patient or absolute non-expansion of the metal stent in 2 patients. In 21 (21.7%) patients in the study group, moderate symptoms of epigastric pain persisted after surgery, while chronic pain syndrome occurred in 4 (4.1%) patients in the postoperative period. 3 months after surgery, 5 (5.1%) patients experienced recurrent obstruction of the stent by a tumor through the stent cells; 9 (9.3%) patients experienced continued tumor growth with stenosis of the lumen. Repeated stent-in-stent ES for tumor stenosis of the stomach and duodenum was performed in 14 (14.4%) patients. Stent migration 3 months after ES of the stomach and duodenum was not recorded in any case. Three-month mortality overall was 14.4% due to progression of the underlying disease. Conclusion. ES of stenosing formations of the outlet of the stomach and duodenum demonstrates an effective and safe low-traumatic surgical intervention, which, as part of palliative care, can achieve a rapid reduction in the clinical symptoms of gastrostasis, rapid restoration of enteral nutrition, and ensure a low incidence of complications, thereby increasing the quality of life in patients with unresectable tumors of the stomach and duodenum.
- Open Access
- 1 November 2023
- Published by Paediatrician Publishers LLC in Annals of the Russian academy of medical sciences
- Vol. 78 (4) , 356-362
Gastrostomy: Evolution of Surgical Techniques
Up to date data analysis of development and advance of gastrostomy surgical technique as well as its evolution are presented in details. Principal technical modalities of gastrostomy creation including laparotomy, miniinvasive laparoscopic approach, percutaneous endoscopic and percutaneous X-ray endoscopic gastrostomy are summarized alongside with their technical pitfalls and disadvantages. Clinical data of gastrostomy is imposed. Possible options of complications caused by technical drawbacks and functioning of gastrostomy are highlighted and described. Analysis of literature review allowed us make the conclusion of percutaneous endoscopic gastrostomy to be the most perspective from the technical and clinical efficacy point of view.
- 1 November 2023
- Published by Paediatrician Publishers LLC in Annals of the Russian academy of medical sciences
- Vol. 78 (4) , 356-362
Open AccessGastrostomy: Evolution of Surgical Techniques
Up to date data analysis of development and advance of gastrostomy surgical technique as well as its evolution are presented in details. Principal technical modalities of gastrostomy creation including laparotomy, miniinvasive laparoscopic approach, percutaneous endoscopic and percutaneous X-ray endoscopic gastrostomy are summarized alongside with their technical pitfalls and disadvantages. Clinical data of gastrostomy is imposed. Possible options of complications caused by technical drawbacks and functioning of gastrostomy are highlighted and described. Analysis of literature review allowed us make the conclusion of percutaneous endoscopic gastrostomy to be the most perspective from the technical and clinical efficacy point of view.
- 1 January 2022
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 12,p. 41-49
Tracheobronchial stenting in patients with non-resectable tumors complicated by airway stenosis
ЦЕЛЬ ИССЛЕДОВАНИЯ Изучить результаты и уровень эффективности проведенного лечения при выполнении эндоскопического стентирования трахеобронхиального дерева у пациентов со стенозирующей нерезектабельной опухолью центральных дыхательных путей. МАТЕРИАЛ И МЕТОДЫ Изучены результаты эндоскопического стентирования трахеобронхиального дерева у 23 пациентов со стенозирующей нерезектабельной опухолью центральных дыхательных путей в период с 2016 по 2021 г. РЕЗУЛЬТАТЫ Частота технического и клинического успеха составила 100%. Интраоперационных осложнений не отмечено. В раннем послеоперационном периоде у всех пациентов разрешилась одышка и зафиксировано объективное улучшение показателей легочной вентиляции — увеличение жизненной емкости легких (с 2,1±0,4 до 2,7±0,5 л; pppp<0,05). У 1 пациента на 3-и сутки после операции зафиксирован эпизод массивного кровотечения на фоне распада опухоли. У 2 пациентов на 2—3-и сутки послеоперационного периода отмечена обтурация стента «слизистой пробкой». Через 3 мес после оперативного вмешательства у 21,8% пациентов выявлены нарушения показателей функции внешнего дыхания, сопровождаемые незначительной одышкой на фоне разрастания грануляционной ткани. Миграция стента через 3 мес после эндоскопического стентирования зафиксирована у 1 пациента. Трехмесячная летальность составила 26,1% на фоне прогрессирования основного заболевания. ЗАКЛЮЧЕНИЕ Эндоскопическое стентирование трахеобронхиального дерева представляет собой безопасное и эффективное малотравматичное оперативное вмешательство, которое в рамках оказания паллиативной помощи позволяет добиться быстрого улучшения функциональных и клинических показателей легочной вентиляции, обеспечить низкую частоту осложнений, что повышает качество жизни у пациентов со стенозирующей нерезектабельной опухолью трахеобронхиального дерева.
- 1 January 2022
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 12,p. 41-49
Tracheobronchial stenting in patients with non-resectable tumors complicated by airway stenosis
ЦЕЛЬ ИССЛЕДОВАНИЯ Изучить результаты и уровень эффективности проведенного лечения при выполнении эндоскопического стентирования трахеобронхиального дерева у пациентов со стенозирующей нерезектабельной опухолью центральных дыхательных путей. МАТЕРИАЛ И МЕТОДЫ Изучены результаты эндоскопического стентирования трахеобронхиального дерева у 23 пациентов со стенозирующей нерезектабельной опухолью центральных дыхательных путей в период с 2016 по 2021 г. РЕЗУЛЬТАТЫ Частота технического и клинического успеха составила 100%. Интраоперационных осложнений не отмечено. В раннем послеоперационном периоде у всех пациентов разрешилась одышка и зафиксировано объективное улучшение показателей легочной вентиляции — увеличение жизненной емкости легких (с 2,1±0,4 до 2,7±0,5 л; pppp<0,05). У 1 пациента на 3-и сутки после операции зафиксирован эпизод массивного кровотечения на фоне распада опухоли. У 2 пациентов на 2—3-и сутки послеоперационного периода отмечена обтурация стента «слизистой пробкой». Через 3 мес после оперативного вмешательства у 21,8% пациентов выявлены нарушения показателей функции внешнего дыхания, сопровождаемые незначительной одышкой на фоне разрастания грануляционной ткани. Миграция стента через 3 мес после эндоскопического стентирования зафиксирована у 1 пациента. Трехмесячная летальность составила 26,1% на фоне прогрессирования основного заболевания. ЗАКЛЮЧЕНИЕ Эндоскопическое стентирование трахеобронхиального дерева представляет собой безопасное и эффективное малотравматичное оперативное вмешательство, которое в рамках оказания паллиативной помощи позволяет добиться быстрого улучшения функциональных и клинических показателей легочной вентиляции, обеспечить низкую частоту осложнений, что повышает качество жизни у пациентов со стенозирующей нерезектабельной опухолью трахеобронхиального дерева.